CR6983A - Antagonistas de receptores de histamina - Google Patents

Antagonistas de receptores de histamina

Info

Publication number
CR6983A
CR6983A CR6983A CR6983A CR6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A CR 6983 A CR6983 A CR 6983A
Authority
CR
Costa Rica
Prior art keywords
histamine
receiver
histamine receiver
receiver antagonists
antagonists
Prior art date
Application number
CR6983A
Other languages
English (en)
Spanish (es)
Inventor
Jenkinson Stephen
Anthony O'reilly Mark
Andrew Trevethick Michael
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CR6983A publication Critical patent/CR6983A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CR6983A 2001-01-17 2003-05-22 Antagonistas de receptores de histamina CR6983A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
CR6983A true CR6983A (es) 2003-11-25

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6983A CR6983A (es) 2001-01-17 2003-05-22 Antagonistas de receptores de histamina

Country Status (31)

Country Link
EP (1) EP1353657A1 (cs)
JP (1) JP2004517883A (cs)
KR (1) KR20030069216A (cs)
CN (1) CN1486178A (cs)
AP (1) AP2002002401A0 (cs)
AR (1) AR032101A1 (cs)
BG (1) BG107834A (cs)
BR (1) BR0206502A (cs)
CA (1) CA2435121A1 (cs)
CR (1) CR6983A (cs)
CZ (1) CZ20031853A3 (cs)
DO (1) DOP2002000325A (cs)
EA (1) EA200300537A1 (cs)
EC (1) ECSP034692A (cs)
EE (1) EE200300335A (cs)
GB (1) GB0101223D0 (cs)
GT (1) GT200200003A (cs)
HU (1) HUP0302767A2 (cs)
IL (1) IL156087A0 (cs)
IS (1) IS6818A (cs)
MA (1) MA26980A1 (cs)
MX (1) MXPA03006408A (cs)
NO (1) NO20033223L (cs)
OA (1) OA12440A (cs)
PA (1) PA8537101A1 (cs)
PL (1) PL362793A1 (cs)
SK (1) SK8572003A3 (cs)
SV (1) SV2003000849A (cs)
TN (1) TNSN02003A1 (cs)
WO (1) WO2002056871A2 (cs)
ZA (1) ZA200304180B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
JP2006510590A (ja) * 2002-09-06 2006-03-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アレルギー及び喘息の処置のためのヒスタミンh4受容体モジュレーターの使用
WO2004066960A2 (en) * 2003-01-28 2004-08-12 Schering Corporation Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2858647B1 (en) 2012-06-08 2018-05-23 Sensorion H4 receptor inhibitors for treating tinnitus

Also Published As

Publication number Publication date
SK8572003A3 (en) 2004-07-07
HUP0302767A2 (hu) 2003-11-28
CZ20031853A3 (cs) 2004-07-14
WO2002056871A2 (en) 2002-07-25
NO20033223D0 (no) 2003-07-16
BR0206502A (pt) 2003-10-21
PA8537101A1 (es) 2002-08-29
EP1353657A1 (en) 2003-10-22
EE200300335A (et) 2003-12-15
ECSP034692A (es) 2003-08-29
CA2435121A1 (en) 2002-07-25
IL156087A0 (en) 2003-12-23
MXPA03006408A (es) 2003-10-15
AR032101A1 (es) 2003-10-22
NO20033223L (no) 2003-07-16
ZA200304180B (en) 2004-06-15
OA12440A (en) 2006-05-22
AP2002002401A0 (en) 2002-03-31
SV2003000849A (es) 2003-01-13
EA200300537A1 (ru) 2004-02-26
DOP2002000325A (es) 2003-01-31
JP2004517883A (ja) 2004-06-17
MA26980A1 (fr) 2004-12-20
BG107834A (bg) 2004-01-30
KR20030069216A (ko) 2003-08-25
PL362793A1 (en) 2004-11-02
GT200200003A (es) 2002-08-19
TNSN02003A1 (fr) 2005-12-23
CN1486178A (zh) 2004-03-31
GB0101223D0 (en) 2001-02-28
IS6818A (is) 2003-05-15

Similar Documents

Publication Publication Date Title
PA8567001A1 (es) Composicion de ziprasidona y controles sinteticos
PA8527201A1 (es) Peptidos ciclados con actividad agonista para el receptor de la melanocortina-4 (mc4-r)
DK1328269T5 (da) Kombination af en CB1-receptorantagonist og sibutramin til behandling af fedme
CY1108649T1 (el) Υποκατεστημενα αρυλπυραζολια ως παρασιτοκτονα
DK1379239T3 (da) N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
PT1300398E (pt) Processos e composicoes para terapias do cancro, utilizando genes que codificam o interferao-beta
CL2004001119A1 (es) Compuestos derivados de oximas; composiciones farmaceutica que los contienen; y su uso como inmunosupresores utiles en enfermedades mediadas por el receptor edg, talees como enfermedades autoinmunes, inflamatorias, infecciosas y cancer.
CR8267A (es) Compuestos de bencimidazolona que tiene actividad agonista del receptor 5-ht4
HN2003000417A (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
ECSP055888A (es) Derivados de aril-quinazolin/aril-2-amino-fenil metanona que promueven la liberación de la hormona paratiroides.
PA8625201A1 (es) Composiciones de peróxido estabilizadas
HN2002000299A (es) Derivados del 3- azabiciclo[3.1.0] hexano
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
NO993350L (no) Vitronectin-reseptor-antagonister
CR6983A (es) Antagonistas de receptores de histamina
SV2004001250A (es) Agonistas muscarinicos ref, x - 15335
BR0312378A (pt) Moduladores de receptores de cck-1
UY26627A1 (es) Antagonistas de receptores de il-8
SV2003001179A (es) Formulacion de 2-metilo-tieno-benzodiacepina liofilizada ref. x-11102
UY27124A1 (es) Antagonistas de receptores de histamina
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
IS7539A (is) Sjálfskammtað getnaðarvarnarídælingarefni úr olíukenndri lausn.
HN2002000355A (es) Combinacion farmaceutica
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling
HN2002000356A (es) Combinacion farmaceutica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)